| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,047,000 | 5,210,500 | 5,209,500 | 5,150,400 | | Cost of Revenue | 816,400 | 915,400 | 1,155,200 | 1,200,900 | | | Gross Profit | 4,230,600 | 4,295,100 | 4,054,300 | 3,949,500 | | | Operating Expenses | | Research Development | 947,300 | 1,059,300 | 953,000 | 951,500 | | Selling General and Administrative | 1,529,200 | 1,726,600 | 1,649,200 | 1,700,100 | | Non Recurring |
-
| 4,765,400 | 1,687,400 | 123,900 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,754,100 | (3,256,200) | (235,300) | 1,174,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,900 | 700 | 46,500 | 74,900 | | Earnings Before Interest And Taxes | 1,771,000 | (3,255,500) | (188,800) | 1,248,900 | | Interest Expense | 87,600 | 81,900 | 44,000 | 42,600 | | Income Before Tax | 1,683,400 | (3,337,400) | (232,800) | 1,206,300 | | Income Tax Expense | 370,300 | 292,000 | 232,800 | 247,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,313,100 | (3,629,400) | (465,600) | 958,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,313,100 | (3,629,400) | (465,600) | 958,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,313,100 | ($3,629,400) | ($465,600) | $958,800 |
|
0.45% Nasdaq 
0.20%
Income Statement
